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Background: Chemically aminoacylated suppressor tRNAs have previously 
been used in vitro to generate mutant proteins in which unnatural amino acids 
are incorporated site-specifically. Although the existing methodology often 
provides adequate quantities of mutant proteins, the suppression efficiencies of 
some unnatural amino acids are not high enough to yield useful amounts of 
protein. In an effort to make this useful mutagenesis strategy more general, we 
report here the results of a search to find alternative tRNAs as a way of 
increasing suppression efficiencies. 
Results: Three suppressor tRNAs have been generated by runoff transcription 
and their ability to deliver unnatural amino acids site-specifically into proteins has 
been assessed in an E. co/i-derived in vitro transcription/translation system. 
Analysis of their ability to insert both polar and nonpolar residues in response to 
an amber codon in two proteins suggests that an f. co/i tRNAASn-derived 
suppressor offers a significant improvement in suppression efficiency over other 
previously used tRNAs. 
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Conclusions: Use of an E. co/i tRNA As”-derived suppressor may provide 
substantially higher yields of proteins containing unnatural amino acids, in 
addition to offering a broader tolerance for polar amino acids. A comparison of 
suppressor tRNAs derived from tRNAASn, tRNAGln or tRNAAsp with that derived 
from tRNAPhe supports emerging evidence that the identity of an amino acid may 
be important in message recognition. 
Introduction 
The ability of tRr\iAs bearing CUA anticodons to deliver 
amino acids in response to an amber (UAG) nonsense codon 
during protein biosynthesis is well documented [l-5]. This 
ability has been exploited to site-specifically incorporate a 
wide variety of unnatural amino acids into specific sites in 
proteins using chemically aminoacylated suppressor tRNAs 
[6--l 11 (Fig. 1). A yeast tRNAPhe-derived suppressor [l&15] 
has been routinely used for this purpose, yet suppression 
efficiencies for certain (mostly polar) amino acids can be 
quite low (<15%), making the production of substantial 
amounts of mutant protein tedious. This has prompted 
a search for improved suppressor tRNAs to be used in 
this methodology. 
A useful tRNA for the introduction of unnatural amino 
acids into proteins must satisfy two criteria. First, the sup- 
pressor tRNA must not be recognized by any aminoacyl 
tRNA synthetase present in the in v&-o transcription-trans- 
lation system, to avoid enzymatic deacylation or acylation 
with an undesired amino acid. Second, the acylated tRNA 
must be readily accepted by the protein biosynthetic 
machinery. The yeast suppressor tRNA that we currently 
use meets the first criterion [16], but poor suppression effi- 
ciencies of certain amino acids may result from its failure 
to uniformly satisfy the latter criterion. In particular, amino 
acids with highly polar sidechains are generally incorpo- 
rated in low yield [17]. This observation may be a general 
result of less favorable interactions of acylated polar amino 
acids with EF-Tu or the ribosome. On the other hand, 
veast tRNAPhe has been shown to bind to the E. co/i ribo- 
some lOOO-fold less tightly than does its E. coL tRNA 
counterpart [18]. This may contribute to reduced suppres- 
sion efficiencies since the cell extract used in our ifz vitro 
translation reactions is derived from E. cob [19,20]. Conse- 
quently, the enhanced affinities of E. coli suppressor 
tRNAs for the ribosome might lead to improved suppres- 
sion efficiencies for the incorporation of unnatural amino 
acids into proteins. 
More than 20 E. coli amber suppressor tRlNAs have been 
constructed and characterized [3-51. Some function as 
excellent suppressor tRNAs in viva, affording more than 
70% insertion of an amino acid in response to the amber 
nonsense codon, while others fail to yield detectable levels 
of suppression. Our development of an improved in vitro 
suppressor tRNA was based on two simple assumptions: (i) 
tRNAs with anticodon loop mutations that do not act as 
efficient suppressors in oiuo are no longer recognized by 
their cognate aminoacyl-tRNA synthetases, and (ii) these 
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tRNAs, if aminoacylated, would be efficiently accepted by 
the protein biosynthetic machinery. These assumptions are 
supported by previous work [5,21] showing that tRNAs 
with anticodon mutations resulting in poor cognate amino- 
acyl-tRNA synthetase recognition can efficiently incorpo- 
rate noncognate amino acids if recognized by noncognate 
aminoacyl-tRNA synthetases. Based on previous studies of 
E. colz’ suppressor tRNAs in which tRNA*“P- and tRNA*“*- 
derived suppressors were found to exhibit poor (co.1 %) 
in V~VO suppression efficiencies [4], these tRNAs were 
deemed promising candidates for the unnatural amino acid 
mutagenesis methodology. These two tRNAs were gener- 
ated as described below and their suppression efficiencies 
were compared with those of the yeast tRNAPhe suppressor 
[l&22], with a previously characterized E. coli tRNAG’y- 
derived suppressor [ll] used in a wheat germ extract 
system, and with a Tetdzymena tRNAG1”(CUA) isoacceptor 
[23] used in an oocyte expression system. In addition, 
an opal (UGA) suppressor derived from the Tetrahymena 
tRNAG1” was prepared and tested for in vitro suppression. 
The tRNAASn-derived suppressor affords high suppression 
efficiencies for both polar and nonpolar amino acids in two 
protein systems, expanding the range of amino acids which 
can be efficiently incorporated using this methodology. 
amber codon at 82 of T4 lysozyme is suppressed with good 
efficiency by the yeast tRNAPhe-derived suppressor, while 
the amber codon at site 88 in E. co& chorismate mutase 
is suppressed with only modest efficiency. Similarly, non- 
polar residues such as valine are known to be inserted by 
the yeast tRNAPhe-derived suppressor with a consistently 
high efficiency of more than 50%, while polar residues 
such as homoglutamate are inserted by this tRNA with a 
much lower efficiency of typically less than 10 %  [lo]. 
Suppression of a nonpolar amino acid 
None of the unacylated amber suppressor tRNAs resulted 
in higher levels of full-length protein (readthrough 
product) than yeast tRNAPhe(CUA) (Fig. 2). The E. co/i 
tRNA*S”(CUA) provided the highest average suppression 
efficiencies of valine in both T4 lysozyme at site 82 and in 
E. col’i chorismate mutase at site 88 of 77% and 75%, 
respectively (Figs 3,4). These efficiencies represent a sig- 
nificant improvement over those of yeast tRNAPhe(CUA), 
which afforded 54% and 50 %  suppression efficiency in 
T4 lysozyme and in chorismate mutase, respectively, and 
represent a smaller improvement over suppression effi- 
ciencies of the Tetrahymena tRNAGrn-derived amber sup- 
pressor. The E. co& tRNA*sP(CUA) and tRNAG’Y(CUA) 
conferred poorer suppression efficiencies for valine in 
both proteins (Figs 3,4). Results 
Translation conditions 
To examine a range of possible in vitro translation condi- Suppression of a polar amino acid 
tions, the suppression efficiencies of two different amino Whereas the yeast tRNA Phe-derived amber suppressor 
acids (valine and homoglutamate) in two proteins (T4 afforded suppression efficiencies for homoglutamate of 
lysozyme and E. colz chorismate mutase) were used to eval- < 10 %  in both T4 lysozyme and chorismate mutase, E. co& 
uate each tRNA. We have previously observed that the tRNA*““(CUA) inserted homoglutamate into these proteins 
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Figure 2 
Nonsense suppression in T4 lysozyme. In vitro 
transcription and translation reactions were 
conducted as described previously [8] in the 
presence of 35S-Met. A 5-k.1 aliquot of each 
30-k.1 reaction was subjected to SDS-PAGE 
(15 %  acrylamide) and quantitation of the 
radiolabeled protein was performed with a 
Molecular Dynamics 44551 Phosphorlmager. 
Lanes l-6, with unacylated tRNA; lanes 
7-l 2, with valine-acylated tRNA; lanes 13-l 8, 
with homoglutamate-acylated tRNA. All 
reactions used a T4 lysozyme gene containing 
a TAG codon at residue 82, with the exception 
of lanes 6, 12 and 18, which used a T4 
lysozyme gene bearing a TGA codon at 
residue 133, and lane 19, which used wild- 
type T4 lysozyme DNA. The identity of the 
tRNA is identified at the top of each lane: Y = 
yeast; E = E. co/i; T = Jetrahymena. 
full-length 
132aa 
81 aa 
with 34 %  and 20 %  efficiencies, respectively. Suppression 
efficiencies with the Te,~~&3,mena tRNAG1”(CUA) were com- 
parable, at 25 %  and 15 %, respectively. Interestingly, E. cali 
tRNAAsP(CUA) incorporated homoglutamate with good 
efficiency into both proteins (21% and 35%, respectively), 
despite comparatively poor suppression of valine (Figs 3,4). 
Opal codon suppression 
Successful suppression of an opal codon with a suppres- 
sor tRNA may provide a route to the production of a 
protein containing two different unnatural amino acids. 
The Te~~/zymenn tRNA Gin-derived opal suppressor was 
generated and aminoacylated as described above. The una- 
cylated tRNA, however, yielded extremely high (>90%) 
levels of readthrough at site 133 in T4 lysozyme and there- 
fore suppression with the aminoacylated tRNA is likely to 
result in the insertion of an unknown mixture of amino 
acids (Fig. 2). Although this high degree of readthrough 
is consistent with previous studies [24] that have found 
differences in context-dependent suppression between 
Figure 3 
Comparison of suppression efficiencies of five 
tRNAs in T4 lysozyme at site 82. Suppression 
efficiencies are defined as the amount of full- 
length protein divided by the sum of the 
full-length and truncated protein produced 
in each reaction. The suppression efficiencies 
shown represent the average of two trials. 
The tRNAs are identified below each bar: 
Y = yeast, E = E. co/i; T = Jetrahymena; 
rt = readthrough (unacylated tRNA); 
V = acylated with valine; hE = acylated 
with homoglutamate. 
r 
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Figure 4 
Comparison of suppression efficiencies of 
five tRNAs in chorismate mutase at site 88. 
Suppression efficiencies are defined as the 
amount of full-length protein divided by the 
sum of the full-length and truncated protein 
produced in each reaction. The suppression 
efficiencies shown represent the average 
of two trials. The tRNAs are identified 
below each bar: Y = yeast, E = E. co/i; 
T = Tetrahymena; rt = readthrough 
(unacylated tRNA); V = acylated with valine; 
hE = acylated with homoglutamate. 
TGA and TAG nonsense codons, we have seen in the past 
that the context effects observed in vZvo are often not con- 
sistent with those found in vitro. The context effects we 
have observed in vitro are complex and thus far suggest 
no simple correlations. It is also possible that this result 
may arise from misacylation of the opal suppressor by an 
endogenous tRNA aminoacyl synthetase. 
Discussion 
Based on the assumption that mutation of the anticodon of 
E. coli tRNAASP and tRNAASn to CUA results in the loss of 
recognition of these tRNAs by their cognate aminoacyl syn- 
thetases, we have examined the utility of these tRNAs for 
in vitro suppression of unnatural amino acids into proteins. 
Low levels of readthrough and good suppression efficien- 
cies for both valine and homoglutamate make the tRNA*““- 
derived amber suppressor an attractive replacement for the 
yeast tRNAPhe-derived suppressor in E. co&derived trans- 
lation systems. Efficient incorporation of homoglutamate 
suggests that the tRNA*“P-derived amber suppressor may 
function well when inserting polar amino acids. Together, 
these tRNAs should significantly enhance our ability to 
generate substantial quantities of protein containing a wide 
variety of unnatural amino acids. An opal suppressor 
derived from the Tetr-ahymena tRNAGin was found to give 
high levels of readthrough product, eliminating the possi- 
bility of using this tRNA to efficiently deliver a second 
unnatural amino acid site-specifically into proteins. 
This work also supports existing evidence that the 
acceptance of an aminoacylated tRNA by one or more 
components of the protein biosynthetic machinery may 
depend in part on the match between the tRNA and its 
covalently bound amino acid. It has been previously 
observed that the EF-Tu in both E. co/i [‘ZS] and 
mammalian [26] systems can discriminate between 
methionine- and N-formyl-methionine-charged tRNAMef. 
Indeed, the poorer suppression efficiencies of polar 
amino acids in the case of the yeast tRNAPhe-derived 
suppressor may be attributable to discrimination by 
EF-Tu. Here we show more generally that suppression 
efficiencies of identical amino acids attached to different 
tRNAs differ depending on the relationship between the 
nature of the amino acid and the tRNA. For example, the 
general trend observed with the yeast tRNAPhe-derived 
suppressor that nonpolar residues are incorporated more 
efficiently than charged amino acids [lo] is reversed with 
the tRNAASp-derived suppressor for suppression at site 
88 of chorismate mutase. In addition, the ratio of incor- 
poration of homoglutamate relative to valine was higher 
in both proteins with tRNAASP-, tRNAASn-, or tRNAG1”- 
derived suppressors than with tRNAPhe- or tRNAG’Y- 
derived suppressors. Discrimination by EF-Tu or other 
translation factors may explain interesting observations 
in this work. Thus the amino acid may indeed have a 
more significant role than that suggested by the original 
‘adaptor hypothesis’ [27], which postulated that message 
recognition is determined exclusively by the tRNA and 
not by the attached amino acid. Our continuing use of 
these new tRNAs to suppress a larger variety of unnat- 
ural amino acids at additional sites will provide important 
data towards the evaluation of this hypothesis. 
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Significance 
Guided by simple design strategies and the previously 
reported properties of suppressor tRNAs, this study has 
found several attractive replacements for the yeast 
tRNAPhe-derived suppressor previously used in v&o to 
deliver unnatural amino acids site-specifically into pro- 
teins. In particular, the E. coli tRNAASn-derived suppres- 
sor satisfied all the criteria of an improved tRNA for 
this method, combining low levels of readthrough with 
high suppression efficiencies for both polar and non- 
polar residues. By increasing both the yields of mutant 
proteins and the range of amino acids capable of being 
incorporated with this methodology, these new tRNAs 
promise to significantly enhance the power of unnatural 
amino acid mutagenesis. This study also contributes to 
the hypothesis that amino acid identity may be a more 
important role in message recognition during translation 
than previously thought. 
Materials and methods 
Constructs for runoff transcription 
All restriction enzymes were purchased from New England Biolabs. 
E. co/i tRNAASP(CUA), tRNAAS”(CUA), and Tetrahymena tRNAGln(UCA) 
were generated from two overlapping synthetic oligonucleotides encod- 
ing the tRNA sequence 141 and the T7 RNA polymerase promoter [221. 
The 5’ nucleotide (nt) of each tRNA was changed, if necessary, to G for 
optimal transcription; in these cases nt 72 was also changed to C to 
restore acceptor stem complementarity. The two annealed oligonu- 
cleotides were filled in with the Klenow fragment of E. co/i DNA poly- 
merase I and inserted between the Kpnl and HindIll sites of plasmid 
pYPhe2 [22] to give plasmids pEAsp, pEAsn, and pTGlnOp. The 
sequences of all constructs were verified by dideoxy DNA sequencing 
[28]. The resulting purified plasmid DNA was digested to completion 
with Fokl to provide template for the transcription of tRNA lacking the 
3’ terminal CA dinucleotide. The modified E. co/i tRNAGly(CUA) [Ill 
was prepared similarly. The plasmid pTHG encoding the Tetrahymena 
tRNAG1”(CUA) [231 was a generous gift from Professor Dennis 
Dougherty (California Institute of Technology). The sequences of the 
E. co/i tRNAASp- and tRNAAsn-derived suppressors [4] are as follows: 
tRNAASp(CUA): 5’-GGAGCGGTAGTTCAGTCGGTTAGAATACCT- 
GCCTCTAACGCAGGGGGTCGCGGGTXGAGTCCCGTCCGTTC- 
CGCCA-3’ 
tRNAAS”(CUA): 5’-GTCCTCTGTAGTTCAGTCGGTAGAACGGCG- 
GACTCTAAATCCGTATGTCACTGGTTCGAGTCCAGTCAGAGGC- 
CGCCA-3’ 
Purification of T7 RNA polymerase 
T7 RNA polymerase was purified as previously described [Bl from 
E. co/i BL21 (pARl219) [29] with the following changes: (1) cell lysis 
was carried out as described except that sonication of the viscous crude 
extract formed after addition of deoxycholate was reduced to three 
lo-15 s cycles (100% duty) at -75% output (35OW) using a 0.5-in 
horn tip (Virtis Virsonic 475 Cell Disrupter). In lieu of sonication, MgCI, 
was added to the crude cell extract to a final concentration of 10 mM 
and RNase-free DNase I (Sigma) was added to a final concentratioh of 
50 pgml-I. The crude cell extract was then incubated at 4’C for -30 
min with mild agitation. (2) An ammonium sulfate fractionation step was 
added. A saturated solution of (NH,),SO, (4“C) was added to the 
supernatant collected after addition of Polymin P (Sigma) to make a 
35 %  saturated solution. After 15 min, the solution was centrifuged at 
39000 x g for 15min. The polymerase was precipitated by addition 
of saturated (NH,),SO, solution to the supernatant to make a 55% 
saturated solution at 4 “C. After a 15 min incubation on ice and centrifu- 
gation, the protein pellet was resuspended in - 10 ml of buffer C [B] plus 
50 mM NaCI. (3) The concentrated crude polymerase was applied to a 
Sephadex G-25 column (24x200mm) equilibrated in buffer C plus 
50 mM NaCl and eluted at a linear flow rate of 5 cm h-l. Precipitation of 
protein will occasionally occur during this desalting step; SDS-PAGE 
analysis of the precipitant shows that T7 RNA polymerase is not a signif- 
icant component of the precipitated protein. The void volume fractions 
containing protein were pooled, diluted with an equal volume of equili- 
*bration buffer, and directly applied to a S-Sepharose FF column 
(15 x 170mm) (Pharmacia) as previously described. (4) Application of 
the protein sample and subsequent wash (buffer C plus 50 mM NaCI) of 
the S-Sepharose FF column were done at a linear flow rate of 65-70 cm 
h-l. The column was washed with equilibration buffer until the A280 of 
the eluant dropped below 0.05AU. T7 RNA polymerase was eluted with 
buffer C plus 200 mM NaCl at a linear flow rate of 9 cm h-‘. (5) Purified 
T7 RNA polymerase eluting from the S-Sepharose FF column was rou- 
tinely pooled based on A,,, with 35% (of peak absorbance) cuts on the 
leading and trailing edge of the elution profile. (6) The purified poly- 
merase was dialyzed (50 kDa MWCO membrane, Spectra/Pro) against 
four 0.5-l changes of buffer C plus 100 mM NaCl and 50 %  glycerol over 
a total of -8 h. The T7 RNA polymerase was aliquoted and flash-frozen 
in liquid nitrogen before being placed into long-term storage at -80°C. 
Production of tRNA 
The Fokl-digested templates were extracted twice with 1 :l phenol:chlo- 
roform, ethanol precipitated, and subjected to runoff transcription using 
T7 RNA polymerase. In vitro transcription reactions were assembled 
at room temperature and contained 40mM Tris-HCI, pH 8.1, 5mM 
DTT, 50 pg ml-’ BSA, 1 OmM spermidine, 15mM MgCI,, 5.75 mM 
each NTP, 0.1 mg ml-’ Fokl digested plasmid template, 0.75U ml-’ 
pyrophosphatase (New England BioLabs), 0.5 U yl-’ RNasin (Promega 
@  40 U PI-‘), and 80 pg ml-l T7 RNA polymerase. Reactions were incu- 
bated at 37°C for 3 h and then extracted with an equal volume of 
phenol/chloroform, and ethanol precipitated. The pellet was dried, 
resuspended in TE, and applied to a NAP-5 desalting column (Pharma- 
cia) to remove NTPs. The purity of the final tRNA product was verified 
by 10% PAGE in the presence of 7 M  urea, and was judged by ethid- 
ium bromide visualization to be 290% for all tRNAs excluding the 
tRNAASn-derived suppressor, which was 280%. In all cases, the major 
impurity was a transcription product one base longer than the desired 
tRNA; deviation from the reaction conditions described above resulted 
in unacceptably high yields of run-on products. Valine or homogluta- 
mate, N-protected as the 4-nitroveratrylcarbamates, were acylated onto 
pdCpA as previously described [B] and the truncated tRNAs were 
ligated to these aminoacylated dinucleotides using T4 RNA ligase [BI. 
Unacylated pdCpA was also ligated to the truncated tRNAs to afford 
full-length unacylated tRNA for use as controls to measure suppres- 
sion due to enzymatic acylation. The ethanol precipitated and washed 
ligation products were dissolved in 1 mM potassium acetate (5 ~1 per 
10~9 tRNA), photodeprotected for 30min at 25°C using a 450W 
mercury immersion lamp with a quartz filter, and added directly to the 
in vitro transcription and translation reactions [Bl. 
Measurement of suppression efficiency 
In vitro transcription and translation reactions with amber suppressor 
tRNAs were performed as described previously [Bl, using plasmids 
encoding either T4 lysozyme bearing a TAG codon at residue 82 [301 or 
E. co/i monofunctional chorismate mutase 25 with a TAG codon at site 
88. Opal suppressions using the Tetrahymena tRNAGln-derived opal 
suppressor were performed using T4 lysozyme plasmid DNA bearing 
a TGA codon at residue 133. The final concentration of divalent magne- 
sium was 3 mM in the T4 lysozyme reactions and 7 mM in the choris- 
mate mutase reactions. The resulting 35S-Met-labeled crude reaction 
mixtures were subjected to SDS-PAGE and the amounts of truncated 
and full-length proteins were quantified using a Molecular Dynamics 
44581 Phospholmager. Suppression efficiencies were defined as the 
amount of full-length protein divided by the sum of the full-length and 
truncated products. 
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